Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg...

FDA Recall #D-0007-2026 — Class II — September 2, 2025

Recall #D-0007-2026 Date: September 2, 2025 Classification: Class II Status: Ongoing

Product Description

Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28

Reason for Recall

Failed Content Uniformity Specifications

Recalling Firm

AvKARE — Pulaski, TN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2192 cartons

Distribution

U.S. Nationwide

Code Information

Lot # LF41138A; Exp 06/30/2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated